Literature DB >> 11252861

The gender gap in cystic fibrosis survival.

P B Davis1.   

Abstract

Females with cystic fibrosis have significantly higher mortality than males from age 1 to age 20, resulting in an approximate four-year difference in median survival age. Survival is associated with a lack of colonization by pathogenic bacteria, as well as better pulmonary function, weight for height, and fitness. This statistically significant gender gap has been observed for decades and, therefore, is not likely to be the result of differential response to one of the newer treatments for cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11252861

Source DB:  PubMed          Journal:  J Gend Specif Med        ISSN: 1523-7036


  19 in total

Review 1.  Endocrine regulation of lung disease and inflammation.

Authors:  Nathalie Fuentes; Patricia Silveyra
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-03

2.  Cystic fibrosis-related diabetes in adults: where can we go from here?

Authors:  Harold W de Valk; Eduard A van der Graaf
Journal:  Rev Diabet Stud       Date:  2007-05-10

Review 3.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

4.  Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype.

Authors:  J Yarden; D Radojkovic; K De Boeck; M Macek; D Zemkova; V Vavrova; R Vlietinck; J-J Cassiman; H Cuppens
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

5.  Elevation of hepatic sulphotransferase activities in mice with resistance to cystic fibrosis.

Authors:  Josie L Falany; Heather Greer; Timea Kovacs; Eric J Sorscher; Charles N Falany
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

6.  Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease.

Authors:  Jessica E Pittman; Elizabeth H Calloway; Michelle Kiser; John Yeatts; Stephanie D Davis; Mitchell L Drumm; Michael S Schechter; Margaret W Leigh; Mary Emond; Annelies Van Rie; Michael R Knowles
Journal:  Pediatr Pulmonol       Date:  2010-12-30

7.  Modulation of cystic fibrosis lung disease by variants in interleukin-8.

Authors:  A D Hillian; D Londono; J M Dunn; K A B Goddard; R G Pace; M R Knowles; M L Drumm
Journal:  Genes Immun       Date:  2008-06-19       Impact factor: 2.676

Review 8.  Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.

Authors:  Christian Krauth; Noushin Jalilvand; Tobias Welte; Reinhard Busse
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

9.  Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients.

Authors:  Hara Levy; Leslie A Kalish; Carolyn L Cannon; K Christopher García; Craig Gerard; Don Goldmann; Gerald B Pier; Scott T Weiss; A A Colin
Journal:  Pediatr Pulmonol       Date:  2008-05

10.  IL1B polymorphisms modulate cystic fibrosis lung disease.

Authors:  Hara Levy; Amy Murphy; Fei Zou; Craig Gerard; Barbara Klanderman; Brooke Schuemann; Ross Lazarus; K Christopher García; Juan C Celedón; Mitch Drumm; Mary Dahmer; Michael Quasney; Kaitlyn Schneck; Melissa Reske; Michael R Knowles; Gerald B Pier; Christoph Lange; Scott T Weiss
Journal:  Pediatr Pulmonol       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.